ArticleCancer medicine2026
Demographic, Clinicopathological Characteristics, and Prognosis of 81 Chinese Elderly Patients With Acral Melanoma.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAcral melanoma (AM) is a rare melanoma subtype involving palms, soles, and nail beds. Clinical-pathological features and survival of elderly AM patients remain insufficiently understood. This study aimed to investigate the characteristics and survival of elderly Chinese AM patients to support clinical management.
methodsConsecutive AM patients aged ≥ 75 years treated at five Chinese melanoma centers between January 2012 and March 2025 were enrolled.
resultsA total of 81 elderly AM patients were included, with median follow-up of 76.0 months and median age of 78 years (55.6% male). Most tumors were located on the sole (80.2%). Stage distribution: I 11.1%, II 49.4%, III 19.8%, IV 8.9%. Median overall survival (OS) was 45.0 months, with 1-, 3-, 5-year OS rates of 88.5%, 60.3%, and 36.5%. Univariate analysis showed that high mitotic rate, ulceration, and advanced stage correlated with shorter OS. Multivariate analysis found no independent predictors for OS. Among 72 surgically treated patients, median disease-free survival (DFS) was 111.0 months, with 1-, 3-, 5-year DFS rates of 76.9%, 63.2%, and 59.9%. Gender was the independent predictor for DFS.
conclusionMultiple clinical-pathological factors affect the prognosis of elderly AM patients. Male sex is an independent predictor of poor DFS. However, due to the limited sample size for endpoint events, this conclusion has certain limitations. These results provide evidence for the clinical management of elderly AM patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.